China Life Sciences Parks Look To Differentiate To Attract Big Pharma Business
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Ten multinational pharmaceutical companies set up R&D centers in China by the end of 2007, most in the booming high-tech parks in Shanghai and Beijing
You may also be interested in...
PhRMA And Beijing-based RDPAC Call For Innovative Medicines To Support China’s Healthcare Reform
SHANGHAI - The Pharmaceutical Research and Manufacturers of America and the Beijing-based R&D Pharmaceutical Association Committee that represents Big Pharma in China, recently submitted a paper to the Chinese government to help the government better understand the role of innovative medicines in the ongoing healthcare reform in China
PhRMA And Beijing-based RDPAC Call For Innovative Medicines To Support China’s Healthcare Reform
SHANGHAI - The Pharmaceutical Research and Manufacturers of America and the Beijing-based R&D Pharmaceutical Association Committee that represents Big Pharma in China, recently submitted a paper to the Chinese government to help the government better understand the role of innovative medicines in the ongoing healthcare reform in China
Venturepharm Rides Chinese Wave Of CRO Growth; Sees Challenges Ahead As Competition Among MNCs, Locals Increase
HONG KONG - The growth of contract research organizations in China has been little short of astounding. China has overtaken India as one of the fastest-growing locations for drug trials, leveraging a huge population and Western-trained doctors into a competitive industry